SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Lucy Gossage, Muhammed Murtaza, Andrew F. Slatter, Conrad P. Lichtenstein, Anne Warren, Beverley Haynes, Francesco Marass, Ian Roberts, Susan J. Shanahan, Andreas Claas, Andrew Dunham, Andrew P. May, Nitzan Rosenfeld, Tim Forshew, Tim Eisen, Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma, Genes, Chromosomes and Cancer, 2014, 53, 1
  2. 2
    Michael T. Parsons, Phillip J. Whiley, Jonathan Beesley, Mark Drost, Niels de Wind, Bryony A. Thompson, Louise Marquart, John L. Hopper, Mark A. Jenkins, Melissa A. Brown, Kathy Tucker, Linda Warwick, Daniel D. Buchanan, Amanda B. Spurdle, Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity, Molecular Carcinogenesis, 2014, 53, 8
  3. 3
    Elif Erturk, Gulsah Cecener, Unal Egeli, Berrin Tunca, Gulcin Tezcan, Sehsuvar Gokgoz, Sahsine Tolunay, Ismet Tasdelen, Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations, Molecular and Cellular Biochemistry, 2014,

    CrossRef

  4. 4
    ZhiFeng Sun, Zhang Zhang, Zidong Liu, Bo Qiu, Kan Liu, Guanglong Dong, MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2, Medical Oncology, 2014, 31, 6

    CrossRef

  5. 5
    A. Bhattacharya, J. D. Ziebarth, Y. Cui, PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways, Nucleic Acids Research, 2014, 42, D1, D86

    CrossRef